Brefel-Courbon C - Search Results

1

Trial of Lixisenatide in Early Parkinson's Disease.

Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O; LIXIPARK Study Group. Meissner WG, et al. Among authors: brefel courbon c. N Engl J Med. 2024 Apr 4;390(13):1176-1185. doi: 10.1056/NEJMoa2312323. N Engl J Med. 2024. PMID: 38598572 Clinical Trial.

2

[Drugs Effect on Cognition in the Elderly].

Brefel-Courbon C. Brefel-Courbon C. Therapie. 2015 Nov-Dec;70(6):523-6. doi: 10.2515/therapie/2015038. Epub 2015 Jul 28. Therapie. 2015. PMID: 26220919 Review. French.

3

Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease.

Gallini A, Gardette V, Vellas B, Lapeyre-Mestre M, Andrieu S, Brefel-Courbon C; REAL.FR/DSA group. Gallini A, et al. Drugs Aging. 2013 Jun;30(6):439-45. doi: 10.1007/s40266-013-0070-3. Drugs Aging. 2013. PMID: 23512718 Free PMC article.

4

[Prevalence of diabetes in france and drug use: study based on the French pharmacovigilance database].

Berthet S, Grolleau S, Brefel-Courbon C, Montastruc JL, Lapeyre-Mestre M. Berthet S, et al. Therapie. 2007 Nov-Dec;62(6):483-8. doi: 10.2515/therapie:2007076. Epub 2008 Mar 4. Therapie. 2007. PMID: 18316014 French.

5

Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease.

Lesage S, Condroyer C, Lannuzel A, Lohmann E, Troiano A, Tison F, Damier P, Thobois S, Ouvrard-Hernandez AM, Rivaud-Péchoux S, Brefel-Courbon C, Destée A, Tranchant C, Romana M, Leclere L, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group. Lesage S, et al. J Med Genet. 2009 Jul;46(7):458-64. doi: 10.1136/jmg.2008.062612. Epub 2009 Apr 8. J Med Genet. 2009. PMID: 19357115

6

[Parkinson "plus"].

Fabre N, Brefel-Courbon C, Rascol O. Fabre N, et al. Rev Prat. 1997 May 15;47(10):1077-82. Rev Prat. 1997. PMID: 9208670 French.

7

Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy.

Rascol O, Sieradzan K, Peyro-Saint-Paul H, Thalamas C, Brefel-Courbon C, Senard JM, Ladure P, Montastruc JL, Lees A. Rascol O, et al. Mov Disord. 1998 Jul;13(4):673-6. doi: 10.1002/mds.870130411. Mov Disord. 1998. PMID: 9686773 Clinical Trial.

8

[Clinical pharmacology of dyskinesias induced by L-dopa in Parkinsonian patients].

Rascol O, Brefel-Courbon C, Blin O. Rascol O, et al. Therapie. 1998 Jan-Feb;53(1):43-8. Therapie. 1998. PMID: 9773099 French.

9

Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.

Thalamas C, Taylor A, Brefel-Courbon C, Eagle S, Fitzpatrick K, Rascol O. Thalamas C, et al. Eur J Clin Pharmacol. 1999 Jun;55(4):299-303. doi: 10.1007/s002280050632. Eur J Clin Pharmacol. 1999. PMID: 10424323 Clinical Trial.

10

Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanisms.

Lazartigues E, Brefel-Courbon C, Tran MA, Montastruc JL, Rascol O. Lazartigues E, et al. Br J Pharmacol. 1999 Aug;127(7):1657-65. doi: 10.1038/sj.bjp.0702678. Br J Pharmacol. 1999. PMID: 10455323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters